Prolonged blood glucose reduction in mrp-2 deficient rats (GY/TR-) by the glucose-6-phosphate translocase inhibitor S 3025

Biochimica et Biophysica Acta - General Subjects

Volumn 1569, Issue 1-3, 2002, Pages 105-110

  Herling, Andreas W ^a   Schwab, Dietmar ^a   Burger, Hans Joerg ^a   Maas, Jochen ^a   Hammerl, Roland ^a   Schmidt, Dietmar ^a   Strohschein, Sabine ^a   Hemmerle, Horst ^a   Schubert, Gerrit ^a   Petry, Stefan ^a   Kramer, Werner ^a  

^a SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

Blood glucose; Glucose 6 phosphate translocase; Hepatobiliary elimination; mrp 2; S 4048

Indexed keywords

1 [2 (4 CHLOROPHENYL)CYCLOPROPYLMETHOXY] 3,4 DIHYDROXY 5 (3 IMIDAZO[4,5 B]PYRIDIN 1 YL 3 PHENYLACRYLOYLOXY)CYCLOHEXANECARBOXYLIC ACID; ENZYME INHIBITOR; GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATE TRANSLOCASE; MULTIDRUG RESISTANCE PROTEIN 2; S 1743; S 3025; S 3483; S 4048; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BILE; BILIARY EXCRETION; CONTROLLED STUDY; DRUG EFFECT; DRUG EXCRETION; DRUG HALF LIFE; ENZYME INHIBITION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HEPATOBILIARY SYSTEM; ISOTOPE LABELING; MALE; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; RADIOACTIVITY; RAT; RAT STRAIN;

ANIMALS; ANTIPORTERS; BILE; BLOOD GLUCOSE; CYTOKINES; DOWN-REGULATION; ENZYME INHIBITORS; IMIDAZOLES; INFUSIONS, INTRAVENOUS; MACROPHAGE INFLAMMATORY PROTEINS; MOLECULAR STRUCTURE; MONOSACCHARIDE TRANSPORT PROTEINS; PHOSPHOTRANSFERASES; PYRIDINES; RATS; RATS, WISTAR; TRITIUM;

RATTUS NORVEGICUS;

EID: 0037081763     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(01)00239-2     Document Type: Article

References (23)

1. Lilly lecture 1987: The triumvirate: Beta-cell, muscle, liver. A collusion responsible for NIDDM
2. Pathophysiology of insulin resistance in human disease
3. Chlorogenic acid analogue S 3483: A potent competitive inhibitor of the hepatic and renal glucose-6-phosphatase systems
4. Plasma glucose levels are reduced in rats and mice treated with an inhibitor of glucose-6-phosphate translocase
5. Hepatic uptake of synthetic chlorogenic acid derivatives by the organic anion transport proteins
6. Pharmacodynamic profile of a novel inhibitor of the hepatic glucose-6-phosphatase system
7. Alterations of carbohydrate and lipid intermediary metabolism during inhibition of glucose-6-phosphatase in rats
8. Upregulation of hepatic glucose-6-phosphatase gene expression in rats treated with an inhibitor of glucose-6-phosphate translocase
9. Recent advances in hepatic glucose-6-phosphatase regulation and function
10. - rats with a hepatobiliary secretion defect
11. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene
12. The canalicular multispecific organic anion transporter and conjugated hyperbilirubinemia in rat and man
13. Expression and localization of the conjugate export pump encoded by the MRP-2 (cMRP/cMOAT) gene in liver
14. Separate transport systems for biliary secretion of sulfated and unsulfated bile acids in the rat
15. Hereditary defect of hepatobiliary cysteinyl leukotriene elimination in mutant rats with defective hepatic anion excretion
16. Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport
17. Secretion of organic anions by hepatocytes: Involvement of homologues of the multidrug resistance protein
18. - rats
19. Chlorogenic acid and synthetic chlorogenic acid derivatives: Novel inhibitors of hepatic glucose-6-phosphate translocase
20. Pharmacological interference with hepatic glucose production
21. Reduced folate derivatives are endogenous substrates for cMOAT in rats